المؤلفون: Paiva, Bruno, Mateos, María Victoria, Sanchez-Abarca, Luis Ignacio, Puig, Noemi, Vidriales, María-Belén, López-Corral, Lucía, Corchete, Luis A, Hernandez, Miguel T, Bargay, Joan, de Arriba, Felipe, de la Rubia, Javier, Teruel, Ana-Isabel, Giraldo, Pilar, Rosiñol, Laura, Prosper, Felipe, Oriol, Albert, Hernández, José, Esteves, Graça, Lahuerta, Juan José, Bladé, Joan, Perez-Simon, Jose Antonio, San Miguel, Jesús F, Spanish Myeloma Group / Program Study and Treatment of Hematological Malignancies cooperative study groups

مصطلحات موضوعية: Adult, Aged, 80 and over, Biomarkers, Tumor, Cell Proliferation, Demography, Dexamethasone, Female, Humans, Immunophenotyping, Induction Chemotherapy, Killer Cells, Natural, Lenalidomide, Longitudinal Studies, Maintenance Chemotherapy, Male, Middle Aged, Multiple Myeloma, Risk Factors, T-Lymphocytes, Thalidomide

العلاقة: http://hdl.handle.net/10668/9664Test; https://ashpublications.org/blood/article-pdf/127/9/1151/1396031/1151.pdfTest

الإتاحة: https://doi.org/10.1182/blood-2015-10-662320Test
http://hdl.handle.net/10668/9664Test
https://ashpublications.org/blood/article-pdf/127/9/1151/1396031/1151.pdfTest

المؤلفون: Benboubker, Lotfi, Dimopoulos, Meletios A., Dispenzieri, Angela, Catalano, John, Belch, Andrew R., Cavo, Michele, Pinto, Antonello, Weisel, Katja, Ludwig, Heinz, Bahlis, Nizar, Banos, Anne, Tiab, Mourad, Delforge, Michel, Cavenagh, Jamie, Geraldes, Catarina, Lee, Je-Jung, Chen, Christine, Oriol, Albert, De La Rubia, Javier, Qiu, Lugui, White, Darrell J., Binder, Daniel, Anderson, Kenneth, Fermand, Jean-Paul, Moreau, Philippe, Attal, Michel, Knight, Robert, Chen, Guang, Van Oostendorp, Jason, Jacques, Christian, Ervin-Haynes, Annette, Avet-Loiseau, Hervé, Hulin, Cyrille, Facon, Thierry, petrini, mario

المساهمون: Benboubker, Lotfi, Dimopoulos, Meletios A., Dispenzieri, Angela, Catalano, John, Belch, Andrew R., Cavo, Michele, Pinto, Antonello, Weisel, Katja, Ludwig, Heinz, Bahlis, Nizar, Banos, Anne, Tiab, Mourad, Delforge, Michel, Cavenagh, Jamie, Geraldes, Catarina, Lee, Je-Jung, Chen, Christine, Oriol, Albert, De La Rubia, Javier, Qiu, Lugui, White, Darrell J., Binder, Daniel, Anderson, Kenneth, Fermand, Jean-Paul, Moreau, Philippe, Attal, Michel, Knight, Robert, Chen, Guang, Van Oostendorp, Jason, Jacques, Christian, Ervin-Haynes, Annette, Avet-Loiseau, Hervã©, Hulin, Cyrille, Facon, Thierry, Petrini, Mario

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Dexamethasone, Disease-Free Survival, Female, Human, Kaplan-Meier Estimate, Male, Melphalan, Middle Aged, Multiple Myeloma, Prednisone, Thalidomide, Medicine (all)

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25184863; info:eu-repo/semantics/altIdentifier/wos/WOS:000341390600008; volume:371; issue:10; firstpage:906; lastpage:917; numberofpages:12; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11568/884323Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84907012637

الإتاحة: https://doi.org/10.1056/NEJMoa1402551Test
http://hdl.handle.net/11568/884323Test

المؤلفون: Paiva, Bruno, Mateos, María Victoria, Sanchez-Abarca, Luis Ignacio, Puig, Noemi, Vidriales, María-Belén, López-Corral, Lucía, Corchete, Luis A, Hernandez, Miguel T, Bargay, Joan, de Arriba, Felipe, de la Rubia, Javier, Teruel, Ana-Isabel, Giraldo, Pilar, Rosiñol, Laura, Prosper, Felipe, Oriol, Albert, Hernández, José, Esteves, Graça, Lahuerta, Juan José, Bladé, Joan, Perez-Simon, Jose Antonio, San Miguel, Jesús F, Spanish Myeloma Group / Program Study and Treatment of Hematological Malignancies cooperative study groups

المساهمون: Instituto de Salud Carlos III, Asociación Española Contra el Cáncer, European Research Council, Red Temática de Investigación Cooperativa en Cáncer (España)

المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instname
Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Dadun. Depósito Académico Digital de la Universidad de Navarra

مصطلحات موضوعية: Adult, Male, medicine.medical_treatment, T-Lymphocytes, Immunology, Biochemistry, Dexamethasone, Immunophenotyping, Maintenance Chemotherapy, 03 medical and health sciences, 0302 clinical medicine, Immune system, Aldesleukin, Risk Factors, hemic and lymphatic diseases, Biomarkers, Tumor, Medicine, Humans, IL-2 receptor, Longitudinal Studies, Lenalidomide, Multiple myeloma, Aged, Cell Proliferation, Demography, Aged, 80 and over, business.industry, Cell Biology, Hematology, Immunotherapy, Induction Chemotherapy, Middle Aged, medicine.disease, Thalidomide, Immunosurveillance, Killer Cells, Natural, body regions, 030220 oncology & carcinogenesis, Female, Ciencias de la Salud::Hematología [Materias Investigacion], business, Multiple Myeloma, CD8, 030215 immunology, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00af9d674b2dda137189561ec4bbb03Test
https://hdl.handle.net/10171/52183Test

المؤلفون: Mateos Manteca, María Victoria, Hernández, Miguel-Teodoro, Giraldo, Pilar, De la Rubia, Javier, De Arriba, Felipe, López Corral, Lucía, Rosiñol, Laura, Paiva, Bruno, Palomera, Luis, Bargay, Joan, Oriol, Albert, Prósper, Felipe, López, Javier, Olavarría, Eduardo, Quintana, Nuria, García, José-Luis, Bladé, Joan, Lahuerta, Juan José, San Miguel Izquierdo, Jesús Fernando

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Dexamethasone, Disease Progression, Female, Follow-Up Studies, Humans, Induction Chemotherapy, Lenalidomide, Male, Middle Aged, Multiple Myeloma, Risk, Survival Rate, Thalidomide, talidomida, protocolos de quimioterapia antineoplásica combinada, dexametasona, humanos, anciano, estudios de seguimiento, mediana edad, mieloma múltiple, riesgo, tasa de supervivencia, quimioterapia de inducción, adulto, progresión de la enfermedad

العلاقة: Mateos, M. V., Hernández, M. T., Giraldo, P., de la Rubia, J., de Arriba, F., Corral, L. L., . & San Miguel, J. F. (2013). Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma. New England Journal of Medicine, 369(5), 438-447. doi:10.1056/NEJMoa1300439. PMID: 23902483.; http://hdl.handle.net/10366/154298Test

الإتاحة: https://doi.org/10.1056/NEJMoa1300439Test
http://hdl.handle.net/10366/154298Test

المؤلفون: LUDWIG, HEINZ, AVET-LOISEAU, HERV, BLAD, JOAN, BOCCADORO, MARIO, CAVENAGH, JAMIE, CAVO, MICHELE, DAVIES, FAITH, DE LA RUBIA, JAVIER, DELIMPASI, SOSANA, DIMOPOULOS, MELETIOS, DRACH, JOHANNES, EINSELE, HERMANN, FACON, THIERRY, GOLDSCHMIDT, HARTMUT, HESS, URS, MELLQVIST, ULF-HENRIK, MOREAU, PHILIPPE, SAN-MIGUEL, JESéS, SONDERGELD, PIA, SONNEVELD, PIETER

المصدر: Oncologist; May2012, Vol. 17 Issue 5, following p592-606, 16p, 2 Diagrams, 5 Charts

مصطلحات موضوعية: ANTINEOPLASTIC agents, COMBINATION drug therapy, FRAIL elderly, GENES, HEMATOPOIETIC stem cell transplantation, MULTIPLE myeloma, QUALITY of life, RISK assessment, THALIDOMIDE, DISEASE relapse, PROGNOSIS, THERAPEUTICS

مصطلحات جغرافية: EUROPE

المؤلفون: De La Rubia, Javier^1,2 (AUTHOR) delarubia_jav@gva.es, Sanz, Miguel A.¹ (AUTHOR)

المصدر: Leukemia & Lymphoma. Jan2011, Vol. 52 Issue 1, p9-14. 6p. 3 Charts.

مصطلحات موضوعية: *MULTIPLE myeloma treatment, *TREATMENT of diseases in older people, *COMBINATION drug therapy, *PREDNISONE, *THALIDOMIDE, *DRUG efficacy, *DRUG side effects

المؤلفون: de la Rubia, Javier^1,2 (AUTHOR) delarubia_jav@gva.es, Such, Esperanza¹ (AUTHOR)

المصدر: Leukemia & Lymphoma. Nov2010, Vol. 51 Issue 11, p1960-1961. 2p.

مصطلحات موضوعية: *MULTIPLE myeloma treatment, *THALIDOMIDE, *TUMOR growth, *PHOSPHOINOSITIDES, *B cell lymphoma, *DIAGNOSIS, *THERAPEUTICS

المؤلفون: Mateos, María-Victoria¹ mvmateos@usal.es, Hernández, Miguel-Teodoro², Giraldo, Pilar³, de la Rubia, Javier⁴, de Arriba, Felipe⁵, Corral, Lucía López¹, Rosiñol, Laura⁶, Paiva, Bruno⁷, Palomera, Luis⁸, Bargay, Joan⁹, Oriol, Albert¹⁰, Prosper, Felipe⁷, López, Javier¹¹, Arguiñano, José-María¹², Quintana, Nuria¹³, García, José-Luis¹³, Bladé, Joan⁶, Lahuerta, Juan-José¹⁴, Miguel, Jesús-F San⁷

المصدر: Lancet Oncology. Aug2016, Vol. 17 Issue 8, p1127-1136. 10p.

مصطلحات موضوعية: *MULTIPLE myeloma treatment, *DEXAMETHASONE, *MULTIPLE myeloma, *MEDICAL protocols, *CLINICAL trials, *DISEASE risk factors, *ANTINEOPLASTIC agents, *COMPARATIVE studies, *LONGITUDINAL method, *RESEARCH methodology, *MEDICAL cooperation, *PROGNOSIS, *RESEARCH, *SURVIVAL, *THALIDOMIDE, *TUMOR classification, *EVALUATION research, *RANDOMIZED controlled trials, *CASE-control method

المؤلفون: Anne Banos, Michel Attal, Salomon Manier, Christine Chen, Jin Lu, Javier de la Rubia, Andrew Belch, Michele Cavo, Angela Dispenzieri, Mourad Tiab, John Catalano, Guang Chen, Lugui Qiu, Aurore Perrot, Je-Jung Lee, Katja Weisel, Hervé Avet-Loiseau, Vanessa Houck, Philippe Moreau, Murielle Roussel, Thierry Facon, Nizar J. Bahlis, Heinz Ludwig, Kenneth C. Anderson, Antonello Pinto, Catarina Geraldes, Xavier Leleu, Bertrand Arnulf, Annette Ervin-Haynes, Albert Oriol, Lotfi Benboubker, Meletios A. Dimopoulos, Daniel Binder, Eileen M Boyle, Cyrille Hulin, Darrell White, Jamie D. Cavenagh, Michel Delforge, Mohamad Mohty

المساهمون: Facon, Thierry, Dimopoulos, Meletios A, Dispenzieri, Angela, Catalano, John V, Belch, Andrew, Cavo, Michele, Pinto, Antonello, Weisel, Katja, Ludwig, Heinz, Bahlis, Nizar J, Banos, Anne, Tiab, Mourad, Delforge, Michel, Cavenagh, Jamie D, Geraldes, Catarina, Lee, Je-Jung, Chen, Christine, Oriol, Albert, De La Rubia, Javier, White, Darell, Binder, Daniel, Jin, Lu, Anderson, Kenneth C, Moreau, Philippe, Attal, Michel, Perrot, Aurore, Arnulf, Bertrand, Qiu, Lugui, Roussel, Murielle, Boyle, Eileen, Manier, Salomon, Mohty, Mohamad, Avet-Loiseau, Herve, Leleu, Xavier, Ervin-Haynes, Annette, Chen, Guang, Houck, Vanessa, Benboubker, Lotfi, Hulin, Cyrille

المصدر: BLOOD
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Blood
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

مصطلحات موضوعية: Melphalan, medicine.medical_specialty, Clinical Trials and Observations, Immunology, Urology, Antineoplastic Agents, Biochemistry, 03 medical and health sciences, 0302 clinical medicine, newly diagnosed multiple myeloma, medicine, Clinical endpoint, Humans, Progression-free survival, Survival analysis, Lenalidomide, business.industry, Hazard ratio, Cell Biology, Hematology, Survival Analysis, Progression-Free Survival, Surgery, Thalidomide, Transplantation, Treatment Outcome, 030220 oncology & carcinogenesis, Multiple Myeloma, business, 030215 immunology, medicine.drug

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e45bdb9fa36b02c60169dd625982ca3Test
https://doi.org/10.1182/blood-2017-07-795047Test

المؤلفون: Rosiñol, Laura¹, Oriol, Albert², Teruel, Ana Isabel³, Hernández, Dolores⁴, López-Jiménez, Javier⁵, de la Rubia, Javier⁶, Granell, Miquel⁷, Besalduch, Joan⁸, Palomera, Luis⁹, González, Yolanda¹⁰, Etxebeste, Ma Asunción¹¹, Díaz-Mediavilla, Joaquín¹², Hernández, Miguel T.¹³, de Arriba, Felipe¹⁴, Gutiérrez, Norma C.¹⁵, Martín-Ramos, Ma Luisa¹⁶, Cibeira, Ma Teresa¹, Mateos, Ma Victoria¹⁵, Martínez, Joaquín¹⁶, Alegre, Adrián¹⁷

المصدر: Blood. 8/23/2012, Vol. 120 Issue 8, p1589-1596. 8p.

مصطلحات موضوعية: *THALIDOMIDE, *DEXAMETHASONE, *MULTIPLE myeloma treatment, *PROTEASOME inhibitors, *STEM cell transplantation, *RANDOMIZED controlled trials, *MEDICAL statistics